<?xml version="1.0" encoding="UTF-8"?>
<p id="para0018">T-705 is a broad-spectrum pyrazinecarboxamide (
 <xref rid="fig0001" ref-type="fig">Fig 1</xref>) that is converted intracellularly to a ribonucleoside analog through phosphoribosylation, thus competitively targeting the viral RdRP complex. Anabolism efficiency can vary between cells of different tissue origin, but has been shown to be low in disease-relevant primary human airway epithelium cells.
 <xref rid="bib0090" ref-type="bibr">
  <sup>90</sup>
 </xref> The drug has broad-spectrum antiviral activity in cell culture, inhibiting RNA viruses of the arenavirus, bunyavirus, flavivirus, alphavirus, norovirus, picornavirus, paramyxovirus, and rhabdovirus families, in addition to influenza viruses.
 <xref rid="bib0091" ref-type="bibr">91</xref>, 
 <xref rid="bib0092" ref-type="bibr">92</xref>, 
 <xref rid="bib0093" ref-type="bibr">93</xref>, 
 <xref rid="bib0094" ref-type="bibr">94</xref>
</p>
